Mark E. Stearns
Affiliations: | Drexel University College of Medicine, Philadelphia, PA, United States |
Area:
Cell BiologyGoogle:
"Mark Stearns"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Amatangelo MD, Goodyear S, Varma D, et al. (2012) c-Myc expression and MEK1-induced Erk2 nuclear localization are required for TGF-beta induced epithelial-mesenchymal transition and invasion in prostate cancer. Carcinogenesis. 33: 1965-75 |
| Wang M, Hu Y, Amantagelo MD, et al. (2012) Retraction: Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer. Molecular Cancer Research : McR. 10: 570 |
| Jun S, Abedin M, Will S, et al. (2012) BSR-8 Establishment and Characterization of a Novel Gallbladder Cell Line to Study the Gender Differences in the Development of Gallbladder Cancer Associated with Gallstones Gender Medicine. 9: S96 |
| Amatangelo MD, Stearns ME. (2012) Reactivation of epithelial-mesenchymal transition in invasive and metastatic cancer Signaling Pathways and Molecular Mediators in Metastasis. 2147483647: 13-69 |
| Stearns ME, Wang M. (2011) Synergistic Effects of the Green Tea Extract Epigallocatechin-3-gallate and Taxane in Eradication of Malignant Human Prostate Tumors. Translational Oncology. 4: 147-56 |
| Wang M, Hu Y, Amatangelo MD, et al. (2011) Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer. Molecular Cancer Research : McR. 9: 36-50 |
| Stearns ME, Wang M. (2011) Synergistic effects of the green tea extract epigallocatechin-3-gallate and taxane in eradication of malignant human prostate tumors1 Translational Oncology. 4: 147-156 |
| Stearns ME, Amatangelo MD, Varma D, et al. (2010) Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: inhibition of metastatic tumor growth in severe combined immunodeficiency mice. The American Journal of Pathology. 177: 3169-79 |
| Abedin MZ, Suresh N, Jun S, et al. (2010) 847 Establishment and Characterization of a Novel Gallbladder Cell Line to Study Gallbladder Cancer and Gallstones Gastroenterology. 138: S-798 |
| Goodyear SM, Kheyfets SB, Garcia FU, et al. (2009) Role of the VEGFR3/VEGFD receptor axis in TGFbeta1 activation of primary prostate cell lines. The Prostate. 69: 982-90 |